307 related articles for article (PubMed ID: 23408461)
41. Clinical usefulness of controlled attenuation parameter to screen hepatic steatosis for potential donor of living donor liver transplant.
Hong YM; Yoon KT; Cho M; Chu CW; Rhu JH; Yang KH; Lee JW
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):805-810. PubMed ID: 28379854
[TBL] [Abstract][Full Text] [Related]
42. Reversal of graft steatosis after liver transplantation: prospective study.
Li J; Liu B; Yan LN; Zuo YX; Li B; Zeng Y; Zhang SF; Li FG
Transplant Proc; 2009 Nov; 41(9):3560-3. PubMed ID: 19917344
[TBL] [Abstract][Full Text] [Related]
43. Surgical assessment of significant steatosis in donor livers: the beginning of the end for frozen-section analysis?
Brunt EM
Liver Transpl; 2013 Apr; 19(4):360-1. PubMed ID: 23447099
[No Abstract] [Full Text] [Related]
44. Donor Small-Droplet Macrovesicular Steatosis Affects Liver Transplant Outcome in HCV-Negative Recipients.
Ferri F; Lai Q; Molinaro A; Poli E; Parlati L; Lattanzi B; Mennini G; Melandro F; Pugliese F; Maldarelli F; Corsi A; Riminucci M; Merli M; Rossi M; Ginanni Corradini S
Can J Gastroenterol Hepatol; 2019; 2019():5862985. PubMed ID: 31187028
[TBL] [Abstract][Full Text] [Related]
45. Safe use of highly steatotic livers by utilizing a donor/recipient clinical algorithm.
Chavin KD; Taber DJ; Norcross M; Pilch NA; Crego H; McGillicuddy JW; Bratton CF; Lin A; Baliga PK
Clin Transplant; 2013; 27(5):732-41. PubMed ID: 23991646
[TBL] [Abstract][Full Text] [Related]
46. Does donor's fatty liver change impact on early mortality and outcome of liver transplantation.
Nikeghbalian S; Nejatollahi SM; Salahi H; Bahador A; Sabet B; Jalaeian H; Geramizadeh B; Dehghani SM; Malek-Hosseini SA
Transplant Proc; 2007 May; 39(4):1181-3. PubMed ID: 17524926
[TBL] [Abstract][Full Text] [Related]
47. MRI steatosis grading: development and initial validation of a color mapping system.
Qayyum A; Nystrom M; Noworolski SM; Chu P; Mohanty A; Merriman R
AJR Am J Roentgenol; 2012 Mar; 198(3):582-8. PubMed ID: 22357996
[TBL] [Abstract][Full Text] [Related]
48. Hepatic steatosis in morbidly obese patients undergoing gastric bypass surgery: assessment with open-system 1H-MR spectroscopy.
van Werven JR; Schreuder TC; Aarts EO; Nederveen AJ; Meijer JW; Berends FJ; Janssen IM; Mulder CJ; Jansen PL; Stoker J
AJR Am J Roentgenol; 2011 Jun; 196(6):W736-42. PubMed ID: 21606262
[TBL] [Abstract][Full Text] [Related]
49. Frozen section diagnosis in donor liver biopsies: observer variation of semiquantitative and quantitative steatosis assessment.
Biesterfeld S; Knapp J; Bittinger F; Götte H; Schramm M; Otto G
Virchows Arch; 2012 Aug; 461(2):177-83. PubMed ID: 22772768
[TBL] [Abstract][Full Text] [Related]
50. Liver steatosis in pre-transplant liver biopsies can be quantified rapidly and accurately by nuclear magnetic resonance analysis.
Bertram S; Myland C; Swoboda S; Gallinat A; Minor T; Lehmann N; Thie M; Kälsch J; Pott L; Canbay A; Bajanowski T; Reis H; Paul A; Baba HA
Virchows Arch; 2017 Feb; 470(2):197-204. PubMed ID: 27915440
[TBL] [Abstract][Full Text] [Related]
51. Macrovesicular steatosis in living related liver donors: correlation of biopsy findings with CT liver attenuation index and body mass index.
Jehangir M; Nazir R; Jang A; Rana A; Rafique S; Dar FS
Clin Transplant; 2016 Sep; 30(9):1016-20. PubMed ID: 27291347
[TBL] [Abstract][Full Text] [Related]
52. Hepatic steatosis in liver transplant donors: rare phenomenon or common feature of donor population?
Hałoń A; Patrzałek D; Rabczyński J
Transplant Proc; 2006; 38(1):193-5. PubMed ID: 16504700
[TBL] [Abstract][Full Text] [Related]
53. An approach to the rational use of steatotic donor livers in liver transplantation.
Urena MA; Moreno Gonzalez E; Romero CJ; Ruiz-Delgado FC; Moreno Sanz C
Hepatogastroenterology; 1999; 46(26):1164-73. PubMed ID: 10370686
[TBL] [Abstract][Full Text] [Related]
54. Expanding postmortem donor pool using steatotic liver grafts: a new look.
Noujaim HM; de Ville de Goyet J; Montero EF; Ribeiro CM; Capellozzi VL; Crescentini F; Casagrande M; Santos RG; Curvello L; de Miranda MP; Genzini T
Transplantation; 2009 Mar; 87(6):919-25. PubMed ID: 19300197
[TBL] [Abstract][Full Text] [Related]
55. Intraoperative assessment of liver organ condition by the procurement surgeon.
Domínguez Fernández E; Schmid M; Bittinger F; Mauer D
Transplant Proc; 2007 Jun; 39(5):1485-7. PubMed ID: 17580168
[TBL] [Abstract][Full Text] [Related]
56. Hepatic steatosis is associated with intrahepatic cholestasis and transient hyperbilirubinemia during regeneration after living donor liver transplantation.
Cho JY; Suh KS; Lee HW; Cho EH; Yang SH; Cho YB; Yi NJ; Kim MA; Jang JJ; Lee KU
Transpl Int; 2006 Oct; 19(10):807-13. PubMed ID: 16961772
[TBL] [Abstract][Full Text] [Related]
57. Donor age and outcome of liver transplantation.
Hoofnagle JH; Lombardero M; Zetterman RK; Lake J; Porayko M; Everhart J; Belle SH; Detre KM
Hepatology; 1996 Jul; 24(1):89-96. PubMed ID: 8707288
[TBL] [Abstract][Full Text] [Related]
58. Hepatic steatosis in liver transplant donors: common feature of donor population?
Garcia Ureña MA; Colina Ruiz-Delgado F; Moreno González E; Jiménez Romero C; García García I; Loinzaz Segurola C; Gonzalez-Pinto ; Gómez Sanz R
World J Surg; 1998 Aug; 22(8):837-44. PubMed ID: 9673556
[TBL] [Abstract][Full Text] [Related]
59. Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.
Park SH; Kim PN; Kim KW; Lee SW; Yoon SE; Park SW; Ha HK; Lee MG; Hwang S; Lee SG; Yu ES; Cho EY
Radiology; 2006 Apr; 239(1):105-12. PubMed ID: 16484355
[TBL] [Abstract][Full Text] [Related]
60. The effects of intermittent inflow occlusion and hepatic steatosis on postoperative liver functions in living liver donors undergoing right hepatectomy.
Shin YH; Ko JS; Kim GS; Gwak MS; Sim WS; Ryu JY; Kim JM; Kwon CH; Joh JW
Transplant Proc; 2012 Mar; 44(2):380-3. PubMed ID: 22410022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
